BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16249221)

  • 1. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation.
    Hofma SH; van der Giessen WJ; van Dalen BM; Lemos PA; McFadden EP; Sianos G; Ligthart JM; van Essen D; de Feyter PJ; Serruys PW
    Eur Heart J; 2006 Jan; 27(2):166-70. PubMed ID: 16249221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired endothelial vasomotor function after sirolimus-eluting stent implantation.
    Fuke S; Maekawa K; Kawamoto K; Saito H; Sato T; Hioka T; Ohe T
    Circ J; 2007 Feb; 71(2):220-5. PubMed ID: 17251671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pioglitazone on endothelial dysfunction after sirolimus-eluting stent implantation.
    Kitahara H; Kobayashi Y; Iwata Y; Fujimoto Y; Komuro I
    Am J Cardiol; 2011 Jul; 108(2):214-9. PubMed ID: 21565324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction.
    Togni M; Windecker S; Cocchia R; Wenaweser P; Cook S; Billinger M; Meier B; Hess OM
    J Am Coll Cardiol; 2005 Jul; 46(2):231-6. PubMed ID: 16022947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of stenting and oral sirolimus on endothelium-dependent and independent coronary vasomotion.
    Fernandes RW; Dantas JM; Oliveira DC; Bezerra HG; Brito FS; Lima VC
    Arq Bras Cardiol; 2012 Apr; 98(4):290-8. PubMed ID: 22406990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion.
    Hamilos MI; Ostojic M; Beleslin B; Sagic D; Mangovski L; Stojkovic S; Nedeljkovic M; Orlic D; Milosavljevic B; Topic D; Karanovic N; Wijns W;
    J Am Coll Cardiol; 2008 Jun; 51(22):2123-9. PubMed ID: 18510958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction.
    Kim JW; Seo HS; Park JH; Na JO; Choi CU; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ
    J Am Coll Cardiol; 2009 May; 53(18):1653-9. PubMed ID: 19406340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction.
    Obata JE; Kitta Y; Takano H; Kodama Y; Nakamura T; Mende A; Kawabata K; Saitoh Y; Fujioka D; Kobayashi T; Yano T; Kugiyama K
    J Am Coll Cardiol; 2007 Oct; 50(14):1305-9. PubMed ID: 17903627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction.
    Shin DI; Kim PJ; Seung KB; Kim DB; Kim MJ; Chang K; Lim SM; Jeon DS; Chung WS; Baek SH; Lee MY
    Int Heart J; 2007 Sep; 48(5):553-67. PubMed ID: 17998765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses.
    Hamilos M; Sarma J; Ostojic M; Cuisset T; Sarno G; Melikian N; Ntalianis A; Muller O; Barbato E; Beleslin B; Sagic D; De Bruyne B; Bartunek J; Wijns W
    Circ Cardiovasc Interv; 2008 Dec; 1(3):193-200. PubMed ID: 20031678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Costa MA; Alfonso F; Gómez-Hospital JA; Hernández-Antolín R; Bañuelos C; Goicolea J; Fernández-Avilés F; Bass T; Escaned J; Moreno R; Fernández C; Macaya C;
    J Am Coll Cardiol; 2006 Jun; 47(11):2172-9. PubMed ID: 16750681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.
    Kim JW; Suh SY; Choi CU; Na JO; Kim EJ; Rha SW; Park CG; Seo HS; Oh DJ
    JACC Cardiovasc Interv; 2008 Feb; 1(1):65-71. PubMed ID: 19393147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials.
    Hoffmann R; Morice MC; Moses JW; Fitzgerald PJ; Mauri L; Breithardt G; Schofer J; Serruys PW; Stoll HP; Leon MB
    Heart; 2008 Mar; 94(3):322-8. PubMed ID: 17761505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation.
    Togni M; Räber L; Cocchia R; Wenaweser P; Cook S; Windecker S; Meier B; Hess OM
    Int J Cardiol; 2007 Aug; 120(2):212-20. PubMed ID: 17234280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term coronary endothelial function after zotarolimus-eluting stent implantation. A 9 month comparison between zotarolimus-eluting and sirolimus-eluting stents.
    Shin DI; Seung KB; Kim PJ; Chang K; Choi JK; Jeon DS; Kim MJ; Lee MY; Chung WS
    Int Heart J; 2008 Nov; 49(6):639-52. PubMed ID: 19075480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation.
    Hong MK; Mintz GS; Lee CW; Park DW; Choi BR; Park KH; Kim YH; Cheong SS; Song JK; Kim JJ; Park SW; Park SJ
    Eur Heart J; 2006 Jun; 27(11):1305-10. PubMed ID: 16682378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease.
    Briguori C; Colombo A; Airoldi F; Focaccio A; Iakovou I; Chieffo A; Michev I; Montorfano M; Bonizzoni E; Ricciardelli B; Condorelli G
    Am Heart J; 2005 Oct; 150(4):807-13. PubMed ID: 16209986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of stem cell mobilization by granulocyte colony-stimulating factor on endothelial function after sirolimus-eluting stent implantation: a double-blind, randomized, placebo-controlled clinical trial.
    Iwata Y; Fujimoto Y; Morino T; Sugimoto K; Ohkubo K; Kadohira T; Fukushima K; Kitahara H; Komuro I; Kobayashi Y
    Am Heart J; 2013 Mar; 165(3):408-14. PubMed ID: 23453111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents.
    Awata M; Kotani J; Uematsu M; Morozumi T; Watanabe T; Onishi T; Iida O; Sera F; Nanto S; Hori M; Nagata S
    Circulation; 2007 Aug; 116(8):910-6. PubMed ID: 17684153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.